Caffeinated Coffee Linked to 18% Lower Dementia Risk in 43-Year Harvard Study

This landmark study provides compelling evidence that caffeinated coffee consumption may protect against cognitive decline and dementia. Researchers followed 131,821 participants for up to 43 years, documenting 11,033 cases of incident dementia—one of the largest and longest studies of its kind.

The research team analyzed dietary data collected every 2-4 years through validated food frequency questionnaires, distinguishing between caffeinated coffee, decaffeinated coffee, and tea consumption. They assessed multiple cognitive outcomes including physician-diagnosed dementia, subjective cognitive decline, and objective cognitive performance through neuropsychological tests.

The results were striking: participants in the highest quartile of caffeinated coffee consumption had 141 dementia cases per 100,000 person-years compared to 330 cases in the lowest quartile—representing an 18% reduction in risk. The protective effect followed a non-linear dose-response pattern, with optimal benefits at 2-3 cups daily. Tea consumption showed similar benefits at 1-2 cups daily, while decaffeinated coffee provided no cognitive protection.

Beyond dementia prevention, higher caffeinated coffee intake was associated with better performance on cognitive tests and reduced subjective cognitive decline. Participants consuming the most caffeinated coffee scored higher on the Telephone Interview for Cognitive Status and reported less perceived cognitive decline.

These findings suggest that caffeine, rather than other coffee compounds, drives the neuroprotective effects. The researchers controlled for numerous confounding factors including age, education, smoking, alcohol consumption, and other dietary factors, strengthening confidence in the results. However, the observational design cannot definitively prove causation, and individual responses to caffeine vary considerably.